Wave Life Sciences is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Our RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Our toolkit of RNA-targeting modalities including RNAi silencing and RNA editing provides us with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Our diversified pipeline is focused on our obesity, alpha-1 antitrypsin deficiency and PNPLA3 I148M liver disease programs and includes clinical programs for Duchenne muscular dystrophy and Huntington’s disease, as well as several preclinical programs utilizing our versatile RNA medicines platform. Driven by the calling to “Reimagine Possible”, we are leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Description: The Executive Director, Clinical Quality Assurance provides strategic leadership, direction and hands on support for clinical quality assurance operations, ensuring compliance with applicable GCP, GVP and GLP regulations as well as any additional applicable regulatory requirements. They are responsible for driving continuous improvement of Good Clinical Practices (GCPs). This role partners closely with GMP Quality Assurance and Discovery and Development senior leaders and stakeholders to develop, implement, and continuously improve global and local GLP/GCP quality strategies that align with Wave program pipeline goals and objectives, setting the overall vision and long-term priorities for the Clinical Quality Assurance organization. This role reports to the Vice President, Regulatory and Policy.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive